Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026)
Cogent Biosciences (COGT) recorded quarterly Amortizatization of Intangibles of $1.2 million in Q1 2026, up 158.77% quarter-over-quarter from $456000.0 in Q4 2025, and up 136.95% on a YoY basis from $498000.0 in Q1 2025.
Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Cogent Biosciences' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 136.95% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $2.6 million (up 36.85% YoY), while the FY2025 annual figure was $2.0 million, up 3.21% from the prior year.
- Amortizatization of Intangibles was $1.2 million for Q1 2026 at Cogent Biosciences, up from $456000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $6.2 million in Q3 2024 to a low of -$3.1 million in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $470529.4 across 5 years, with a median of $491000.0 in 2022.
- Biggest YoY gain for Amortizatization of Intangibles was 2162.77% in 2024; the steepest drop was 1688.78% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then slumped by 83.42% to $196000.0 in 2023, then plunged by 1688.78% to -$3.1 million in 2024, then jumped by 114.64% to $456000.0 in 2025, then surged by 158.77% to $1.2 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.2 million (Q1 2026), $456000.0 (Q4 2025), and $506000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | 456,000.00 |
| Dec 31, 2025 | 456,000.00 |
| Sep 30, 2025 | 506,000.00 |
| Sep 30, 2025 | 506,000.00 |
| Jun 30, 2025 | 502,000.00 |
| Jun 30, 2025 | 502,000.00 |
| Mar 31, 2025 | 498,000.00 |
| Mar 31, 2025 | 498,000.00 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 467,000.00 |
| Mar 31, 2024 | 467,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Dec 31, 2023 | 196,000.00 |